Dfran Lund News Today

Lund is the fifth Distinguished Fellow from UAB named since 2019, a sign of the strength of immunology research at UAB. Fran Lund, Ph.D.Fran Lund, Ph.D., a professor of microbiology at the University of Alabama at Birmin...

A small blood donation can help UAB researchers and doctors learn how better to use immunology to treat disease. Needed: 5,000 healthy volunteers, who are willing to give a small blood sample if called in the future. Thi...

Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. In a study published in the journal Immunity, researchers describe a distinct and novel subset of memory B cells that predict long-lived antibody resp

Nine out of 10 patients with systemic lupus erythematosus -; the autoimmune disease also known as SLE -; are females.

Two immunologists say an intranasal Covid vaccine can elicit an immune response at the site of infection – the respiratory tract. Intranasal vaccination, which is administered through the nose, is also needle-free, meaning that more people may be willing to get vaccinated. Ultimately, using both intramuscular and intranasal Covid vaccines may be effective in combating Covid-19. Out of the 108 Covid-19 vaccines that are currently undergoing clinical trials, only eight are delivered intranasall...

UAB is leading the way in research for an intranasal vaccine against COVID-19 which they say could be beneficial for many reasons.

COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial UAB and Altimmune collaborate on COVID-19 vaccine trial (Source: UAB) By WBRC Staff | February 19, 2021 at 3:24 PM CST - Updated February 19 at 3:24 PM BIRMINGHAM, Ala. (WBRC) - A big update in the COVID-19 vaccine testing at the University of Alabama at Birmingham. The Altimmune Inc. vaccine candidate that was tested at UAB in 2020 is expected to start patient enrollment for its Phase 1 clinical trial next we...